A novel C-3-substituted oleanolic acid benzyl amide derivative exhibits therapeutic potential against influenza A by targeting PA–PB1 interactions and modulating host macrophage inflammation
Open Access
- 29 May 2025
- journal article
- Published by Elsevier in Acta Pharmaceutica Sinica B
- Vol. 15 (8) , 4156-4173
Abstract
No abstract availableKeywords
Funding Information
- Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences and Peking Union Medical College (ZZ13-035-02)
- National Natural Science Foundation of China (82073722)
- Basic and Applied Basic Research Foundation of Guangdong Province (2025A1515010495)
- Basic and Applied Basic Research Foundation of Guangdong Province (2023A1515111165)
- Special Fund Project for Science and Technology Innovation Strategy of Guangdong Province (2022ZDZ08)
- Innovative Research Group Project of the National Natural Science Foundation of China
- China Academy of Traditional Chinese Medicine
This publication has 37 references indexed in Scilit:
- Detection of influenza A(H3N2) viruses with polymerase acidic subunit substitutions after and prior to baloxavir marboxil treatment during the 2022–2023 influenza season in JapanAntiviral Research, 2024
- Tackling Influenza A virus by M2 ion channel blockers: Latest progress and limitationsEuropean Journal of Medicinal Chemistry, 2024
- Nine-valent oleanolic acid conjugates as potent inhibitors blocking the entry of influenza A virusEuropean Journal of Medicinal Chemistry, 2023
- Discovery of novel aporphine alkaloid derivative as potent TLR2 antagonist reversing macrophage polarization and neutrophil infiltration against acute inflammationActa Pharmaceutica Sinica B, 2023
- Thermodynamic and structural characterization of an optimized peptide-based inhibitor of the influenza polymerase PA-PB1 subunit interactionAntiviral Research, 2022
- Vitisin B inhibits influenza A virus replication by multi-targeting neuraminidase and virus-induced oxidative stressActa Pharmaceutica Sinica B, 2022
- Small molecule SMU-CX24 targeting toll-like receptor 3 counteracts inflammation: A novel approach to atherosclerosis therapyActa Pharmaceutica Sinica B, 2022
- Potent and broad-spectrum cycloheptathiophene-3-carboxamide compounds that target the PA-PB1 interaction of influenza virus RNA polymerase and possess a high barrier to drug resistanceAntiviral Research, 2019
- Structure-activity relationships of 3-O-β-chacotriosyl oleanic acid derivatives as entry inhibitors for highly pathogenic H5N1 influenza virusBioorganic & Medicinal Chemistry, 2017
- Structure-activity relationships of 3-O-β-chacotriosyl oleanane-type triterpenoids as potential H5N1 entry inhibitorsEuropean Journal of Medicinal Chemistry, 2016